PEG-IFN-alfa 2b WITH RIBAVIRIN FOR THE PREVENTION OF HISTOLOGICAL FIBROSIS PROGRESSION IN PATIENTS WITH HCV HEPATITIS RECURRENCE. A MULTICENTER RANDOMIZED CONTROLLED STUDY. INTERIM REPORT
- Publication date
- 1 January 2009
- Publisher
- Wiley-blackwell Publishing, Inc